Study of CPI-100 in Patients With Advanced Tumors

Clinical trial NCT03781362 · COMPLETED

Trial details

NCT number: NCT03781362
Sponsor: Coordination Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Tumors

Start date: 2018-12-21
Primary completion: 2022-06-21
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.